![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Dixon JM, Renshaw L, Young O . 2008. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer. Journal of Clinical Oncology 26:1671–1676.
- Karlsson E, Lindström LS, Wilking U . 2010. Discordance in hormone receptor status in breast cancer during tumor progression (Abstr 1009). Journal of Clinical Oncology 28:15s.
- Erkanli S, Kayaselcuk F, Kuscu E . 2006. Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy. Breast 15:558–561.
- Hara F, Kiyoto S, Takabatake D . 2010. Endometrial metastasis from breast cancer during adjuvant endocrine therapy. Case Reports in Oncology 3: 137–141.
- Lamovec J, Bracko M. 1991. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. Journal of Surgical Oncology 48:28–33.
- Mazoujian G, Bodian C, Haagensen DE . 1989. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer 63:2156–2161.
- Mazur MT, Hsueh S, Gersell DJ. 1984. Metastases to the female genital tract. Analysis of 325 cases. Cancer 53:1978–1984.
- Moll R, Mitze M, Frixen UH . 1993. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. American Journal of Pathology 143:1731–1742.
- Nathanson SD, Kwon D, Kapke A . 2009. The role of lymph node metastasis in the systemic dissemination of breast cancer. Annals of Surgical Oncology 16:3396–3405.
- Pestalozzi BC, Zahrieh D, Mallon E . 2008. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. Journal of Clinical Oncology 26:3006–3014.
- Sastre-Garau X, Jouve M, Asselain B . 1996. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77:113–120.
- Tornos C, Soslow R, Chen S . 2005. Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. American Journal of Surgical Pathology 29:1482–1489.
- Ustaalioglu BB, Bilici A, Seker M . 2009. Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy. Onkologie 32:424–426.